Gamma-H2AX as a biomarker to assess individual radiosensitivity for radiopharmaceutical therapy in cancer patients: a systematic review
, , , , , , , , and
Radioprotection, 60 3 (2025) 285-292
Published online: 15 September 2025
DOI: 10.1051/radiopro/2025004
